Pharmaceutical industry news

Moderna's COVID Vaccine Was a Historic Success. Could Its Cancer Vaccine Be Even Bigger?

US FDA To Hold Psychedelic Drug Hearing Amid Trump Push: What It Means For Depression, PTSD

New FDA Hepatic Impairment Guidance: What It Means for Your Next Dedicated Study

Is Krystal Biotech (KRYS) Cheap On Its Cantor Conference Spotlight?

BTIG raises Cullinan Oncology stock price target on trial data

OWKIN Highlights AI-Driven Forecasting for Phase 3 Clinical Trial Outcomes

Major updates for Apple’s software platforms are now available

Siri AI, a profoundly more capable and personal assistant, is here

GenSci registers Phase I trial of four-target retinal fusion protein across three indications

Apple’s new child safety features now available

Lilly cans early experimental obesity drug after ‘high bar’ not met

Meet Naomi: Running Strong with Latent Autoimmune Diabetes in Adults

BioMarin Pharmaceutical (BMRN), What Is Behind The Fresh Attention?

Experts urge FDA to set clear safety and access standards for psychedelic drugs

A Day at Camp: Discovery Base at Beaumont

FREE: ADA Family Day at the Louisiana Children's Museum

Lung cancer screening: cooperation for efficient processes and digital networking

Promising Biotech Stocks To Follow Today - September 14th

AI in pharma: Accelerating development with Microsoft | The Microsoft Cloud Blog

A Path to Stability at FDA?

Divided We Fall: New book explores polarization, citizenship and Canada’s democratic future

Extracting CBD: from artisanal practice to industrial production

RTW Biotech Opportunities Ltd Reports Earnings Results for the Half Year Ended June 30, 2026

PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing

PDS Biotechnology Reports Initial Closing of Private Financing

No more Nordisk: Novo’s latest trim is in its name

FDA places partial clinical hold on Biohaven's epilepsy drug days after $795 million SK Biopharmaceuticals deal

Séverine - Technicienne de Laboratoire

Souraya - Technicienne de fabrication

Cover of vaccination evaluated rapidly (COVER) programme 2026 to 2027: quarterly data

Percentage of children immunised under the cover of vaccination evaluated rapidly (COVER) programme...

3 Biotech Industry Trends Reshaping the Healthcare Market

Fabien - Pharmacien

DHSC public appointments: 2026 to 2027

Non-executive appointments to the Department of Health and Social Care's public bodies and committee...

New Haven biotech seeks to raise $150M for drug development

Midcap biotech outlook: CMPS leads on trend, momentum, and catalyst timing

企業活動と医療機関等および患者団体の関係における透明性に関する指針等に基づき、「2025年度 医療機関等への資金提供等の実績」、「2025年度 患者団体への資金提供等の実績」を公開しました

Saved by CPR at 15, college freshman leads walk to build a nation of lifesavers

UBC scientists uncover why some Huntington disease patients decline years earlier

Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy

Shaping the future of medicine

Dengue: the green book chapter

Dengue immunisation information for public health professionals.

US FDA Grants Priority Review to Zasocitinib for Moderate to Severe PsO

PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors

PDS Biotechnology Raises $11.3 Million in Initial Closing of PIPE Led by Nant Capital; Dr. Soon-Shiong Joins Board

Gustave Roussy et The Lancet lancent une série de conférences internationales sur les innovations qui transforment la cancérologie

UK government response to the Covid-19 Inquiry Module 3 report

The UK government response to the UK Covid-19 Inquiry Module 3 report on the impact of the pandemic...

From ambition to delivery: is the National Cancer Plan properly funded?

A cancer biotech raises $11.3 million. The Los Angeles Times owner joins its board.

Gotistobart: Lung cancer drug candidate prolonged lives in trial

Definium Therapeutics (DFTX) Stock Soars 20% on Successful Phase 3 Anxiety Trial Results

Prevenzione dei tumori testa-collo: torna la Make Sense Campaign

Stifel cuts Olema Pharmaceuticals price target on trial concerns By Investing.com

UC Irvine selected as new home of UC Global Health Institute

Vivek Malhotra awarded the FEBS Theodor Bücher Lecture and Medal 2027

NIFST, stakeholders seek evidence-based regulation of low-calorie sweeteners

BioMarin Pharmaceutical appoints Robert Plenge to board of directors

Immunocore Achieves Full Enrollment in Phase 3 TEBE-AM Melanoma Study

REZILIENT3 Trial: Efficacy and Safety Data of Zipalertinib in EGFR Exon 20 Insertion NSCLC

Recce Pharmaceuticals (ASX:RCE): Phase 3 Diabetic Foot Infection Trial and MENA Licensing Update

Positive Topline Results From Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder